| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/15/2005 | US6855511 Fructosamine oxidase assay: methods and materials |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855503 Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing |
| 02/15/2005 | US6855501 Transfer of arrayed chemical compositions |
| 02/15/2005 | US6855500 Fluorescence-based genotyping |
| 02/15/2005 | US6855498 In-situ hybridization probes for the detection of microsporidial species |
| 02/15/2005 | US6855497 Detecting spinocerebellar ataxia; obtain tissue sample, incubate with probe, hybridization of probe indicates spinocerebellar ataxia |
| 02/15/2005 | US6855496 Detection of preferential nucleic acid ligands; obtain nucleotide sequences, incubate with oligonucleotides, hybridize, amplify, recover nucleotide sequences |
| 02/15/2005 | US6855491 Device for rapidly diagnosing upper respiratory conditions |
| 02/15/2005 | US6855365 Recombinant bacterial phytases and uses thereof |
| 02/15/2005 | US6855323 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
| 02/15/2005 | US6855315 Kits for detecting swine infertility and respiratory syndrome (SIRS) virus |
| 02/15/2005 | CA2110828C Transition metal complexes having 2,2'-bipyridine ligands substituted by at least one ammonium alkyl radical, their method of manufacture and use thereof as a redox mediator |
| 02/12/2005 | CA2476398A1 Microencapsulation of oxygen-sensing particles |
| 02/10/2005 | WO2005013091A2 Methods, software arrangements, storage media, and systems for genotyping or haplotyping polymorphic genetic loci or strain identification |
| 02/10/2005 | WO2005013081A2 Methods and systems for applying genetic operators to determine system conditions |
| 02/10/2005 | WO2005012911A1 Analytical method for pancreatin and comparable compositions |
| 02/10/2005 | WO2005012909A1 Methods of forming monolayers of phage-derived products and uses thereof |
| 02/10/2005 | WO2005012906A1 Mechanochemical type sensor |
| 02/10/2005 | WO2005012901A2 Method for measuring aromatase activity |
| 02/10/2005 | WO2005012900A1 Biosensor with multiple electrical functionalities |
| 02/10/2005 | WO2005012899A2 Method for error detection and increased confidence of sample decoding |
| 02/10/2005 | WO2005012876A2 Methods of screening compositions for g protein-coupled receptor desensitization inhibitory activity |
| 02/10/2005 | WO2005012875A2 Biomarkers of cyclin-dependent kinase modulation |
| 02/10/2005 | WO2005012874A2 Nanostructured material transport devices and their fabrication by application of molecular coatings to nanoscale channels |
| 02/10/2005 | WO2005012871A2 Increasing bias for oxygen production in an electrode system |
| 02/10/2005 | WO2005012579A2 Homodimeric cyanine dye dimer comprising aromatic, heteroaromatic, cyclic or heterocyclic linker moiety in nucleic acid reporter molecules |
| 02/10/2005 | WO2005012578A1 Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions for genotyping of polymorphisms |
| 02/10/2005 | WO2005012577A1 Methods and compositions for modulating cell proliferation |
| 02/10/2005 | WO2005012576A2 Molecular markers for the selection of soybean plants having superior agronomic performance |
| 02/10/2005 | WO2005012575A1 Methods and compositions related to the use of sequence-specific endonucleases for analyzing nucleic acids under non-cleaving conditions |
| 02/10/2005 | WO2005012574A2 Biological bar-code |
| 02/10/2005 | WO2005012573A1 Microarray comprising probes for drug-resistant hepatitis b virus detection, quality control and negative control, and method for detecting drug-resistant hepatitis b virus using the same |
| 02/10/2005 | WO2005012572A1 Screening method of reassortant influenza viruses using primer dependent multiplex rt-pcr |
| 02/10/2005 | WO2005012571A1 Partially double stranded nucleic acid molecule |
| 02/10/2005 | WO2005012570A1 METHOD OF EVALUATING COMPOUND EFFICACIOUS IN TREATING OBESITY BY USING Slc25a10 |
| 02/10/2005 | WO2005012569A1 Methods and kits for predicting the likelihood of successful treatment of cancer |
| 02/10/2005 | WO2005012568A2 In vitro gene expression assay for determining fluoropyrimidine sensitivity in chemotherapy |
| 02/10/2005 | WO2005012567A1 Methods and kits for detecting an enzyme capable of modifying a nucleic acid |
| 02/10/2005 | WO2005012566A2 Use of polymorphisis in human oatp-c associated with an effect on statin pharmacokinetics in humans in statin therapy |
| 02/10/2005 | WO2005012565A1 Genetic marker for coronary artery disease |
| 02/10/2005 | WO2005012564A1 Genetic marker for coronary artery disease |
| 02/10/2005 | WO2005012563A1 Method for quantifying and assessing the viability of neospora caninum in samples of bovine semen |
| 02/10/2005 | WO2005012562A1 Screening assay for anti-bacterial compounds |
| 02/10/2005 | WO2005012561A1 Microarray devices having controllable reaction volume |
| 02/10/2005 | WO2005012560A1 Obesity markers and uses thereof |
| 02/10/2005 | WO2005012559A1 Methods of using a sterol biosynthesis pathway reporter gene to screen for antifungal or lipid lowering compounds |
| 02/10/2005 | WO2005012558A1 Protease assay |
| 02/10/2005 | WO2005012557A1 Method of collecting erythrocytes and method of assaying sorbitol |
| 02/10/2005 | WO2005012555A1 Method for the detection of coliforms and in particular escherichia coli |
| 02/10/2005 | WO2005012554A1 On-chip bioassy method and kit |
| 02/10/2005 | WO2005012551A2 Interaction of nmda receptor with protein tyrosine phosphatase |
| 02/10/2005 | WO2005012550A2 Screening methods and libraries of trace amounts of dna from uncultivated microorganisms |
| 02/10/2005 | WO2005012548A2 Self-hybridizing multiple target nucleic acid probes and methods of use |
| 02/10/2005 | WO2005012545A2 Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors |
| 02/10/2005 | WO2005012544A2 Methods for the identification of inhibitors of mannosyltransferase and mannosyltransferase complex subunit as antibiotics |
| 02/10/2005 | WO2005012543A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 02/10/2005 | WO2005012526A1 Lafora's disease gene |
| 02/10/2005 | WO2005012522A1 Clean-up beads |
| 02/10/2005 | WO2005012501A2 Free-solution dna sequencing |
| 02/10/2005 | WO2005012500A2 Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology |
| 02/10/2005 | WO2005012499A2 Methods for amplifying polymeric nucleic acids |
| 02/10/2005 | WO2005012497A2 Translocation tagging |
| 02/10/2005 | WO2005012445A2 Conducting inks |
| 02/10/2005 | WO2005012329A2 Kinase and phosphatase assays |
| 02/10/2005 | WO2005011947A2 Image processing method and system for microfluidic devices |
| 02/10/2005 | WO2005011610A2 Neurodegenerative protein aggregation inhibition methods and compounds |
| 02/10/2005 | WO2005005629A3 Uridyl glucose pyrophosphorylase as target for fungicides |
| 02/10/2005 | WO2004106548A3 Method for conducting single nucleotide polymorphisms (snp)-analysis on biochips having oligonucleotide areas |
| 02/10/2005 | WO2004106489A3 Nematode GS-like sequences |
| 02/10/2005 | WO2004101749A3 Methods for amplification of nucleic acid sequences using staggered ligation |
| 02/10/2005 | WO2004097358A3 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) |
| 02/10/2005 | WO2004094675A3 Compositions and methods for determining the presence of sars coronavirus in a sample |
| 02/10/2005 | WO2004091372A3 Methods of assessing crohn’s disease patient phenotype by i2, ompc and asca serologic response |
| 02/10/2005 | WO2004081179A3 Regulation of rna stability |
| 02/10/2005 | WO2004062591A3 Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases |
| 02/10/2005 | WO2004058050A3 Amplified cancer target genes useful in diagnosis and therapeutic screening |
| 02/10/2005 | WO2004047614A3 Methods, biosensors and kits for detecting and identifying fungi |
| 02/10/2005 | WO2004044139A3 Modified oligonucleotides for use in rna interference |
| 02/10/2005 | WO2004043332A3 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 02/10/2005 | WO2004042034A3 Method for the linear amplification of complementary dna |
| 02/10/2005 | WO2004039953A3 Array oligomer synthesis and use. |
| 02/10/2005 | WO2004038007A3 Dna polymerases with reduced base analog detection activity |
| 02/10/2005 | WO2004024068A3 Novel composition and methods for the treatment of immune related diseases |
| 02/10/2005 | WO2004019001A3 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 02/10/2005 | WO2004003167A3 Gucy1b2 genetic markers for ldl cholesterol response to statin therapy |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003060065A3 Adapter-directed display system |
| 02/10/2005 | WO2003058194A3 Affinity labeling of enzymes for detection of enzyme activity level in living cells |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | WO2003025117A3 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 02/10/2005 | WO2003012676A3 Method for calculating a characteristic property of a molecule by correlation analysis |
| 02/10/2005 | WO2002072872A3 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby |
| 02/10/2005 | WO2002064626A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/10/2005 | WO2002020718A3 Osteoclast-associated receptor |
| 02/10/2005 | US20050034185 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 02/10/2005 | US20050033900 System, method, and computer software product for specifying parameters associated with a biological probe array |
| 02/10/2005 | US20050033524 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation |
| 02/10/2005 | US20050033520 Methods and compositions for utilizing changes of hybridization signals during approach to equilibrium |
| 02/10/2005 | US20050033132 Analyte measuring device |